These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 4225264)

  • 21. [Determination of the total complement activity of serum and of 4 fractions: C'1, C'2, C'3, C'4].
    Brécy H; André A; Hartmann L
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):1024-8. PubMed ID: 5598511
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of total complementary activity and of its 4 fractions: C'1, C'2, C'3 and C'4 in the serum and urine].
    Hartmann L; Brécy H
    Ann Biol Clin (Paris); 1969; 27(7):559-70. PubMed ID: 5354248
    [No Abstract]   [Full Text] [Related]  

  • 23. STUDIES ON HUMAN C'1-ESTERASE. II. FUNCTION OF PURIFIED C'1-ESTERASE IN THE HUMAN COMPLEMENT SYSTEM.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():468-78. PubMed ID: 14131465
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of the fractions of complement (C'1, C'2, C'3, C'4) in hypocomplimentary glomerulopathies].
    Lagrue G; Brécy H; Bariéty J; Milliez P; Hartmann L
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):990-5. PubMed ID: 5598513
    [No Abstract]   [Full Text] [Related]  

  • 25. A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum.
    Jensen JA
    J Exp Med; 1969 Aug; 130(2):217-41. PubMed ID: 4893886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum complement and C'1, C'2, C'3 and C'4 components in rheumatoid arthritis and collagen diseases].
    Pietruska Z
    Pol Tyg Lek; 1972 Dec; 27(51):2010-3. PubMed ID: 4653713
    [No Abstract]   [Full Text] [Related]  

  • 27. [C'1-esterase and C'1-esterase inhibitor in the serum of patients with hereditary genuine Quincke's edema].
    Gottstein U; Yoo DJ; Büttner H
    Klin Wochenschr; 1967 Mar; 45(5):230-5. PubMed ID: 5592432
    [No Abstract]   [Full Text] [Related]  

  • 28. Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
    Gigli I; Nelson RA
    Exp Cell Res; 1968 Jul; 51(1):45-67. PubMed ID: 5661952
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].
    Peltier AP; Vial MC; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):959-67. PubMed ID: 4921319
    [No Abstract]   [Full Text] [Related]  

  • 30. COMPARISON OF THE AGGLUTINABILITY BY RHEUMATOID ARTHRITIC SERA OF SENSITIZED SHEEP CELLS, EXPOSED TO HUMAN C'1, C'4 AND C'2.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1963; 59():73-8. PubMed ID: 14064807
    [No Abstract]   [Full Text] [Related]  

  • 31. ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.
    DONALDSON VH; ROSEN FS
    J Clin Invest; 1964 Nov; 43(11):2204-13. PubMed ID: 14223932
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.
    Austen KF; Becker EL
    J Exp Med; 1966 Sep; 124(3):397-416. PubMed ID: 4162486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism.
    Lundh B; Laurell AB; Wetterqvist H; White T; Granerus G
    Clin Exp Immunol; 1968 Sep; 3(7):733-45. PubMed ID: 5701955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observations on a pro-esterase associated with partially purified first component of human complement (C'1).
    LEPOW IH; RATNOFF OD; ROSEN FS; PILLEMER L
    Proc Soc Exp Biol Med; 1956 May; 92(1):32-7. PubMed ID: 13336065
    [No Abstract]   [Full Text] [Related]  

  • 35. Enzymatic and immunochemical estimation of C'1 esterase inhibitor in sera from patients with hereditary angioneurotic edema.
    Laurell AB; Lindegren J; Malmros I; Mårtensson H
    Scand J Clin Lab Invest; 1969 Oct; 24(3):221-5. PubMed ID: 5375738
    [No Abstract]   [Full Text] [Related]  

  • 36. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.
    Dias Da Silva W; Lepow IH
    J Exp Med; 1967 May; 125(5):921-46. PubMed ID: 4960742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COMPLEMENT AND HEMOLYTIC ANTIBODY: CHANGES IN THEIR ACTIVITY INDUCED BY MERCAPTOETHANOL.
    FRANK MM; BORSOS T; RAPP HJ
    Science; 1965 Feb; 147(3659):742-3. PubMed ID: 14242020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
    MUELLER-EBERHARD HJ; BIRO CE
    J Exp Med; 1963 Sep; 118(3):447-66. PubMed ID: 14078003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of the first component of human complement in vitro.
    Colten HR; Gordon JM; Borsos T; Rapp HJ
    J Exp Med; 1968 Oct; 128(4):595-604. PubMed ID: 5675435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of C'1 to C'1 esterase on gel filtration on Sephadex G-200. Studies on normal human serum, euglobulin and hereditary angioneurotic edema serum.
    Laurell AB; Siboo R
    Acta Pathol Microbiol Scand; 1966; 68(2):230-42. PubMed ID: 5958663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.